HANSAINVEST reports 2.65% stake in Hinge Health

Hinge Health, Inc. ownership filing: HANSAINVEST Hanseatische Investment-Limited Co reports beneficial ownership of 1,476,600 ordinary shares, representing 2.65% of Hinge Health's class of ordinary shares.

Rhea-AI Filing Summary

Hinge Health, Inc. ownership filing: HANSAINVEST Hanseatische Investment-Limited Co reports beneficial ownership of 1,476,600 ordinary shares, representing 2.65% of Hinge Health's class of ordinary shares. The ownership figure is stated as of December 31, 2025 and the Schedule 13G was signed on April 27, 2026.

The filing states HANSAINVEST has sole voting and dispositive power over the shares under German law (Sec. 93 (1) KAGB) and notes the shares are held for the account of investment funds managed by HANSAINVEST.

Insights

Institutional Ownership Analyst

HANSAINVEST reports a passive stake of 1,476,600 shares (2.65%) in Hinge Health.

Schedule 13G filings are typically used to report passive or qualifying institutional holdings; this submission lists sole voting and dispositive power exercised under the firm’s German KVG authority. The ownership is dated December 31, 2025.

Materiality is limited: a 2.65% stake is notable for disclosure but does not itself imply control or a change in governance. Future filings could show changes if HANSAINVEST increases or reduces its position.

Key Figures

Shares beneficially owned: 1,476,600 shares Percent of class: 2.65% Ownership date: as of December 31, 2025 +2 more

5 metrics

Shares beneficially owned 1,476,600 shares Amount beneficially owned reported in Schedule 13G

Percent of class 2.65% Percent of Hinge Health ordinary shares (as reported)

Ownership date as of December 31, 2025 Date to which the ownership figure applies

Filing signature date April 27, 2026 Date the Schedule 13G was signed

CUSIP 433313103 Hinge Health ordinary shares CUSIP listed in the filing

Key Terms

Schedule 13G, KVG, beneficially owned, sole dispositive power

4 terms

Schedule 13G regulatory

"HANSAINVEST Hanseatische Investment-Limited Co reports beneficial ownership"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

KVG regulatory

"German KVG (Investment Management Company)"

beneficially owned financial

"Amount beneficially owned: 1,476,600.00"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 1,476,600.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does HANSAINVEST report in HNGE?

HANSAINVEST reports owning 1,476,600 ordinary shares, or 2.65%. The filing states this ownership is as of December 31, 2025 and reflects sole voting and dispositive power under German KVG law.

What does Schedule 13G mean for Hinge Health (HNGE)?

Schedule 13G reports institutional passive ownership rather than an activist intent. It notifies the market that an institutional investor holds a disclosed stake; the filing does not state any plans to seek control or change governance.

Who signed the Schedule 13G for HANSAINVEST?

The filing was signed by Pascal Reyer, Director of Reporting, on April 27, 2026. The signature certifies the regulatory comparability of HANSAINVEST's German KVG regime to U.S. institutional rules.

What voting power does HANSAINVEST claim on these shares?

HANSAINVEST reports sole voting power and sole dispositive power over 1,476,600 shares. The filing explains this authority operates under German law (Sec. 93 (1) KAGB) for shares held for managed investment funds.

What date is the ownership figure tied to in the filing?

The ownership amount is reported as of December 31, 2025. The Schedule 13G itself was signed and submitted on April 27, 2026, per the filing signature block.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 07:26 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Hinge Health, Inc.

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)

433313103

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 433313103

1

Names of Reporting Persons

HANSAINVEST Hanseatische Investment-Limited Co

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

GERMANY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,476,600.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,476,600.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,476,600.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.7 %

12

Type of Reporting Person (See Instructions)

OO, FI

Comment for Type of Reporting Person: The shares are held for the account of investment funds managed by HANSAINVEST. Under German law HANSAINVEST is not the legal owner of these shares which are co-owned by the investors. However by operation of German law (Sec. 93 (1) KAGB) HANSAINVEST is authorized to exercise the ownership rights to vote the shares and has full dipositive power over the shares. The ownership information above is as of 31th of December 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Hinge Health, Inc.
(b)	Address of issuer's principal executive offices: 455 MARKET STREET, 7TH FLOOR, SAN FRANCISCO, CALIFORNIA, 94105.
Item 2.
(a)	Name of person filing: Pascal Reyer
(b)	Address or principal business office or, if none, residence: Kapstadtring 8 22297 Hamburg Germany
(c)	Citizenship: German
(d)	Title of class of securities: Ordinary Shares
(e)	CUSIP Number(s): 433313103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	German KVG (Investment Management Company)
Item 4.	Ownership
(a)	Amount beneficially owned: 1,476,600.00
(b)	Percent of class: 2.65 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,476,600.00
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,476,600.00
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Investment Management Company (KVG) is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

HANSAINVEST Hanseatische Investment-Limited Co

Signature:	Pascal Reyer
Name/Title:	Director of Reporting
Date:	04/27/2026